Digistain is mentioned in TechCrunch

Honoured to get a mention in TechCrunch – the respected voice in high-tech news!

“Here are all the companies from Y Combinator’s Summer 2021 Demo Day, Part 1. Today Y Combinator kicked off the Demo Day cycle for its Summer 2021 cohort. The collection of early-stage startups on day one-of-two alone numbered in the hundreds. Digistain: One of several startups in this cohort taking on the cancer market, Digistain wants to use infrared scanning to better understand which breast cancer patients are truly a fit for chemotherapy. Its view is that more folks than needed get chemotherapy, which is not only expensive but can actually kill you. I am not an expert on regulatory approval, but using tech to avoid taking poison juice to the jugular sounds pretty great.”

Supported by:

royal society logo
NIHR logo
cancer research uk logo
BIVDA logo

Subscribe to leading news and insights

To stay updated about Digistain’s developments, enter your details opposite. We promise only to send you important news.